title: Race or genetic makeup for hepatitis C virus treatment decisions?
authors.affiliation: Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
authors.forename: Thomas R
authors.initials: TR
authors.lastname: O'Brien
authors.affiliation: Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD.
authors.forename: Shyam
authors.initials: S
authors.lastname: Kottilil
authors.affiliation: Toronto Centre for Liver Disease, University of Toronto, Toronto, Canada.
authors.forename: Jordan J
authors.initials: JJ
authors.lastname: Feld
authors.affiliation: VA Long Beach Healthcare System, Long Beach, CA.
authors.forename: Timothy R
authors.initials: TR
authors.lastname: Morgan
authors.affiliation: Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
authors.forename: Ruth M
authors.initials: RM
authors.lastname: Pfeiffer
mesh_terms: D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000821:virology*; D006801:Humans; D044469:Racial Groups